招募中 NCT06820606

比較Rezum與Urolift

前列腺癌不適用

這是一項採用非劣效性設計的隨機對照試驗,受試者按1:1隨機分配至水蒸氣熱治療(REZUM)組或前列腺尿道提升術(UroLift)組。

適應症:Prostate Cancer

收案條件

納入條件

  • Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml

排除條件

  • History or high suspicion of prostate cancer
  • Current urinary tract infection
  • Refractory urinary retention or post-void residual (PVR) ≥250 mL
  • Intravesical prostatic protrusion (IPP)\>10mm
  • Prior prostate surgery
  • Known or suspected allergy to nickel, titanium, or polyester/polypropylene
  • Urethral stricture, meatal stenosis, bladder neck contracture
  • Neurogenic bladder and/or sphincter abnormalities

收案條件維持 ClinicalTrials.gov 原始英文登錄資料,實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源:ClinicalTrials.gov,每兩週自動更新,最後同步:2026年10月8日。